Toni19 Posted - 58 minutes ago

$RVPH https://www.gurufocus.com/insider/127436/rahul-nayar#history Mizuho Securities is also a 10% holder, Rahul Nayar too! Then we have Vedanta with 20%, Lax with 10%, Tenzing with 10%, Tang with 10%, Armistice with more then 6%! When my calculation is right, we have around 80% in insider and other big hands! So, the free float must be very thin! You can also check by Insider Fintel. @Univego , @LeoKitCat

Toni19 Posted - 1 hour ago

$RVPH https://www.wsj.com/livecoverage/stock-market-today-earnings-04-18-2024/card/heard-on-the-street-abbvie-s-bet-on-a-neuroscience-drug-maker-just-got-better-YfSQD892sWusoWIuNoTT?siteid=yhoof2 Interesting stuff!!😏@Univego, @LeoKitCat @Biscuitpants

8park8park Posted - 4 hours ago

$RVPH

Univego Posted - 5 hours ago

$RVPH https://www.afr.com/policy/health-and-education/the-evolution-of-schizophrenia-treatment-in-australia-20240418-p5fkzt?utm_medium=social&utm_campaign=nc&utm_source=LinkedIn#Echobox=1713493318

Toni19 Posted - 5 hours ago

$RVPH https://www.gurufocus.com/insider/127436/rahul-nayar#history Interesting stuff!! @Univego @Biscuitpants @LeoKitCat

Eaglelanded Posted - 22 hours ago

$RVPH ceo is the worst!

ButcherBillCutting Posted - 22 hours ago

$RVPH Could only add beer money in Warrants today

Univego Posted - 1 day ago

$RVPH

Univego Posted - 1 day ago

$RVPH https://www.linkedin.com/feed/update/urn:li:activity:7186415632421171201?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7186415632421171201%29

WonnoW Posted - 2 days ago

$RVPH

rocket_buddy Posted - 3 days ago

$RVPH seems like a dbl digit value today for me, imo… Very

Univego Posted - 3 days ago

$RVPH https://scr.zacks.com/news/news-details/2024/RVPH-Update-to-Brilaroxazine-Safety-vs.-Efficacy-Comparison--Adding-RECOVER-Data-article/default.aspx

Univego Posted - 3 days ago

$RVPH https://www.tipranks.com/news/company-announcements/reviva-pharmaceuticals-advances-schizophrenia-treatment-trials

Univego Posted - 3 days ago

$RVPH https://za.investing.com/news/revivas-schizophrenia-drug-moves-forward-with-fda-study-acceptance-93CH-3092696

Univego Posted - 3 days ago

$RVPH https://www.linkedin.com/feed/update/urn:li:activity:7185733003115995136?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7185733003115995136%29

Univego Posted - 3 days ago

$RVPH Today we reported financial results for the full year ended December 31, 2023 and summarized recent business highlights. 2023 was an exciting and productive year for Reviva that included significant progress in the late-stage development of our brilaroxazine program for schizophrenia. In the year ahead, we also expect topline data from our 1-year OLE trial in the fourth quarter which will inform on the long-term safety and efficacy of brilaroxazine. With these important trials advancing and most non-clinical activities complete, we are targeting a potential NDA submission in the third quarter of 2025. For more details please read our press release: https://lnkd.in/gDEbzcNF

Biscuitpants Posted - 3 days ago

$RVPH FYI...Armamino was the auditor for Reviva and signed off on their year-end 2022 financial statements as well as auditing the first three quarters of 2023....thinking they are liable for Reviva having to restate their financial statements for multiple periods in 2022 and 2033. Armanino should have identified the accounting irregularities as part of their audit process. The below article states Armanino backed out of public company audits on July 25, 2023. At this same time, Reviva filed an 8-K to document this. https://news.bloombergtax.com/financial-accounting/former-ftx-auditor-armanino-quietly-quits-public-company-audits

Toni19 Posted - 3 days ago

$RVPH The p3 results on 4 weeks were compelling! The 50mg hit every endpoint! The efficacy and safety data is clear! The next phase merely needs to be confirmatory AND put the 30mg in play. Thats it, thats all! Don't over complicate it. There is no conspiracy! From DTM Y board

GI197845 Posted - 3 days ago

$RVPH Is the below news regarding phaseIIIb for Schizophrenia? Or, has phaseIIIb not even started yet, do'h!? Reviva Pharmaceuticals has gained alignment with the U.S. FDA on its registrational Phase 3 program for brilaroxazine in schizophrenia 8:33 AM ET 4/15/24 | Briefing.com FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study.Two positive 4-week studies plus a 12-month long-term safety study have potential to support a New Drug Application for brilaroxazine in schizophrenia.Topline data from 1-year open-label extension long-term safety trial expected in Q4 2024.

History101 Posted - 3 days ago

$RVPH from yahoo: Fro 2 hours ago There has been no slippage in NDA submission timelines.... The February 15 KOL presentation...Next Steps slide 48: Planned new drug application (NDA) submission to the FDA expected in 2025. Today PR...Collectively, we expect to have completed all of the outlined NDA submission requirements by the third quarter of 2025.” The NDA submission timeline has been MOVED FORWARD

Univego Posted - 3 days ago

$RVPH https://www.linkedin.com/feed/update/urn:li:activity:7185660488091930625?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7185660488091930625%29

Univego Posted - 4 days ago

$RVPH https://scr.zacks.com/analyst-bios/person-details/default.aspx?ItemId=dd01b998-53e1-4448-9b1a-8fe0a6a3c606

Univego Posted - 4 days ago

$RVPH https://scr.zacks.com/news/news-details/2024/RVPH-Update-to-Brilaroxazine-Safety-vs.-Efficacy-Comparison--Adding-RECOVER-Data-article/default.aspx

Univego Posted - 4 days ago

$RVPH https://scr.zacks.com/news/news-details/2024/RVPH-Update-to-Brilaroxazine-Safety-vs.-Efficacy-Comparison--Adding-RECOVER-Data-article/default.aspx

Univego Posted - 4 days ago

$RVPH https://www.linkedin.com/feed/update/urn:li:activity:7185626531958771712?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7185626531958771712%29

Univego Posted - 4 days ago

$RVPH https://www.linkedin.com/feed/update/urn:li:activity:7185657136046051329?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7185657136046051329%29

Biscuitpants Posted - 4 days ago

$RVPH There has been NO SLIPPAGE of the NDA submission timeline... The February 15 KOL presentation...Next Steps slide 48: Planned new drug application (NDA) submission to the FDA expected in 2025. Today PR...Collectively, we expect to have completed all of the outlined NDA submission requirements by the third quarter of 2025.” The NDA submission timeline has been MOVED FORWARD.

Univego Posted - 4 days ago

$RVPH https://revivapharma.com/reviva-announces-fda-alignment-on-brilaroxazine-clinical-trials-for-nda-in-schizophrenia/

Univego Posted - 4 days ago

$RVPH A good purchase price for a share whose drug will beapproved.✅✅✅✅ It is rare to be so sure based on the excellent data. Think out of the box👍

dcrown Posted - 4 days ago

$RVPH Jezz WS really hates this